Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category : Drug factories
Languages : en
Pages : 48
Book Description
Holders of Approved Drug Applications for Drugs Presenting Actual Or Potential Bioequivalence Problems
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category : Drug factories
Languages : en
Pages : 48
Book Description
Publisher:
ISBN:
Category : Drug factories
Languages : en
Pages : 48
Book Description
Holders of approved new drug applications for drugs presenting actual or potential bioequivalence problems
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category :
Languages : en
Pages : 52
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 52
Book Description
Approved Prescription Drug Products
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 16
Book Description
Accompanied by supplements.
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 16
Book Description
Accompanied by supplements.
Generic drug entry prior to patent expiration an FTC study
Author:
Publisher: DIANE Publishing
ISBN: 1428951938
Category :
Languages : en
Pages : 129
Book Description
Publisher: DIANE Publishing
ISBN: 1428951938
Category :
Languages : en
Pages : 129
Book Description
Competitive problems in the drug industry
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities
Publisher:
ISBN:
Category :
Languages : en
Pages : 988
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 988
Book Description
Hearings, Reports and Prints of the Senate Select Committee on Small Business
Author: United States. Congress. Senate. Select Committee on Small Business
Publisher:
ISBN:
Category : Legislative hearings
Languages : en
Pages : 1556
Book Description
Publisher:
ISBN:
Category : Legislative hearings
Languages : en
Pages : 1556
Book Description
Monthly Catalog of United States Government Publications
Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1194
Book Description
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1194
Book Description
Generic
Author: Jeremy A. Greene
Publisher: Johns Hopkins University Press
ISBN: 142142164X
Category : Medical
Languages : en
Pages : 375
Book Description
The turbulent history of generic pharmaceuticals raises powerful questions about similarity and difference in modern medicine. Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals in this gripping narrative, are never based on being identical to the original drug in all respects, but in being the same in all ways that matter. How do we know what parts of a pill really matter? Decisions about which differences are significant and which are trivial in the world of therapeutics are not resolved by simple chemical or biological assays alone. As Greene reveals in this fascinating account, questions of therapeutic similarity and difference are also always questions of pharmacology and physiology, of economics and politics, of morality and belief. Generic is the first book to chronicle the social, political, and cultural history of generic drugs in America. It narrates the evolution of the generic drug industry from a set of mid-twentieth-century "schlock houses" and "counterfeiters" into an agile and surprisingly powerful set of multinational corporations in the early twenty-first century. The substitution of bioequivalent generic drugs for more expensive brand-name products is a rare success story in a field of failed attempts to deliver equivalent value in health care for a lower price. Greeneās history sheds light on the controversies shadowing the success of generics: problems with the generalizability of medical knowledge, the fragile role of science in public policy, and the increasing role of industry, marketing, and consumer logics in late-twentieth-century and early twenty-first century health care.
Publisher: Johns Hopkins University Press
ISBN: 142142164X
Category : Medical
Languages : en
Pages : 375
Book Description
The turbulent history of generic pharmaceuticals raises powerful questions about similarity and difference in modern medicine. Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals in this gripping narrative, are never based on being identical to the original drug in all respects, but in being the same in all ways that matter. How do we know what parts of a pill really matter? Decisions about which differences are significant and which are trivial in the world of therapeutics are not resolved by simple chemical or biological assays alone. As Greene reveals in this fascinating account, questions of therapeutic similarity and difference are also always questions of pharmacology and physiology, of economics and politics, of morality and belief. Generic is the first book to chronicle the social, political, and cultural history of generic drugs in America. It narrates the evolution of the generic drug industry from a set of mid-twentieth-century "schlock houses" and "counterfeiters" into an agile and surprisingly powerful set of multinational corporations in the early twenty-first century. The substitution of bioequivalent generic drugs for more expensive brand-name products is a rare success story in a field of failed attempts to deliver equivalent value in health care for a lower price. Greeneās history sheds light on the controversies shadowing the success of generics: problems with the generalizability of medical knowledge, the fragile role of science in public policy, and the increasing role of industry, marketing, and consumer logics in late-twentieth-century and early twenty-first century health care.
FDA Drug Bulletin
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 594
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 594
Book Description
Annual Report
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 184
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 184
Book Description